Remove Development Remove Health Care Remove Technology Remove Venture Capitalist
article thumbnail

Precision Medicine Could Have a Major Impact on Healthcare Outcomes and Costs - SPONSOR CONTENT FROM SIEMENS HEALTHINEERS

Harvard Business Review

The transformation of health care continues at a rapid pace, bringing opportunities and challenges for health care providers to deliver improved clinical outcomes at lower costs. And many health care systems continue to struggle to reliably deliver evidence-based care.

Cost 8
article thumbnail

Should Big Companies Give Up on Innovation?

Harvard Business Review

It’s a common question thrown at me by entrepreneurs, venture capitalists, or the more cynically minded corporate leaders. Start-up companies tend to cluster in industries favored by venture capitalists (like biotechnology or information technology) or ones where there are relatively low barriers to entry (like restaurants).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Reversing the Decline in Big Ideas

Harvard Business Review

Many venture capitalists are up in the arms because their returns are down, their funds are drying up, and there appear to be a declining number of entrepreneurs pursuing big ideas. Unfortunately, venture capitalists have mixed up their causality. The internet and, more broadly, technology, progress developmentally.

article thumbnail

Reversing the Decline in Big Ideas

Harvard Business Review

Many venture capitalists are up in the arms because their returns are down, their funds are drying up, and there appear to be a declining number of entrepreneurs pursuing big ideas. Unfortunately, venture capitalists have mixed up their causality. The internet and, more broadly, technology, progress developmentally.

article thumbnail

Artificial Intelligence Is Almost Ready for Business

Harvard Business Review

AI, expert systems, and business intelligence have been with us for decades, but this time the reality almost matches the rhetoric, driven by the exponential growth in technology capabilities (e.g., The biggest application of Watson has been in health care. But it seems we’re now at an actual tipping point.

article thumbnail

How Merck Is Trying to Keep Disrupters at Bay

Harvard Business Review

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

article thumbnail

The 5 Things IBM Needs to Do to Win at AI

Harvard Business Review

Twenty years ago, Louis Gerstner transformed IBM by emphasizing consulting and technology services — not just technology — to solve customer problems. How technology is changing the way we work. Develop a portfolio of capabilities with different risk/return profiles. Can the elephant dance again?